The Recall Desk
HighCPSC·20724·Announced 2020-03-18

NumbSkin Pain Relief Cream Recalled for Child-Resistant Packaging Failure

SeeNext Venture is recalling NumbSkin pain relief cream because the packaging is not child-resistant, posing a risk of poisoning to young children.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (poisoning risk to children) where injury has not yet been reported, which aligns with the 'High' severity criteria in the rubric.

Plain-English summary

SeeNext Venture Ltd. is recalling approximately 8,000 units of NumbSkin pain relief cream with 5% lidocaine. The recall is due to the product's failure to meet the child-resistant packaging requirements of the Poison Prevention Packaging Act. The cream was sold online at Amazon.com from October 2019 through February 2020 for about $25. The product is a 30-gram white and blue tube with Lot 9238 and a date code of 10/2019 through 09/2020 embossed on the thin end.

The hazard is that the packaging is not child-resistant, which poses a risk of poisoning to young children if they put the lidocaine cream on their skin or ingest it. No injuries or illnesses have been reported in connection with this recall.

Consumers should immediately store the pain relief cream in a safe location out of reach of children. They should contact SeeNext Venture for instructions on how to dispose of or return the product to receive a free replacement with a child-resistant cap. Amazon is also contacting all known purchasers directly. Consumers can reach SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, or via email at [email protected].

The recalled product

Product
NumbSkin pain relief cream with lidocaine
Affected units
8,000

Distribution

Distributed nationwide across the United States.